Cislini Jeff sold RVMD
March 18, 2024 · Form 4 insider transaction
Cislini Jeff sold 1,252 shares of Revolution Medicines, Inc. at $31.58 per share, a transaction worth $39.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,252
Price
$31.58
Total value
$39.5K
InsiderCislini Jeff
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 18, 2024
Filing dateMarch 20, 2024
Shares owned after55,874
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.; Includes 48,972 RSUs.